We are live on ! Find out more
CT

Cambridge Trust Portfolio holdings

AUM $2.64B
1-Year Est. Return 28.73%
This Fund
S&P 500
This Quarter Est. Return
-13.22%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.28B
AUM Growth
-$571M
Cap. Flow
-$160M
Cap. Flow %
-7.02%
Top 10 Hldgs %
27.44%
Holding
985
New
54
Increased
140
Reduced
331
Closed
122

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$13.7M
2
KO icon
Coca-Cola
KO
+$10.7M
3
CVS icon
CVS Health
CVS
+$9.84M
4
GTLS
Chart Industries
GTLS
+$4.3M
5
ETN icon
Eaton
ETN
+$4.11M

Sector Composition

Rank Sector Weight
1 Technology 18.07%
2 Financials 16.12%
3 Healthcare 14.36%
4 Consumer Discretionary 9.42%
5 Miscellaneous 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
26
Home Depot
HD
$329B
$27.2M 1.19%
99,307
-2,840
-3% -$838K
AVGO icon
27
Broadcom
AVGO
$1.75T
$26.6M 1.17%
548,020
-4,780
-0.9% -$268K
PLD icon
28
Prologis
PLD
$134B
$25.1M 1.1%
213,344
-7,892
-4% -$1.09M
NVS icon
29
Novartis
NVS
$292B
$24.6M 1.08%
291,222
+12,158
+4% +$1.07M
IEF icon
30
iShares 7-10 Year Treasury Bond ETF
IEF
$42.9B
$23.7M 1.04%
231,569
+39,685
+21% +$4.07M
WM icon
31
Waste Management
WM
$87.8B
$23.3M 1.02%
152,530
-11,231
-7% -$1.76M
KO icon
32
Coca-Cola
KO
$386B
$22.8M 1%
361,807
+169,499
+88% +$10.7M
LOW icon
33
Lowe's Companies
LOW
$117B
$22.6M 0.99%
129,402
-2,890
-2% -$557K
DHR icon
34
Danaher
DHR
$152B
$22.5M 0.99%
100,198
-52,653
-34% -$12.1M
MRK icon
35
Merck
MRK
$366B
$22.4M 0.98%
245,899
+19,827
+9% +$1.76M
CVS icon
36
CVS Health
CVS
$119B
$22.3M 0.98%
240,910
+100,822
+72% +$9.84M
BLK icon
37
Blackrock
BLK
$180B
$22.2M 0.97%
36,449
-1,280
-3% -$833K
PANW icon
38
Palo Alto Networks
PANW
$303B
$22M 0.96%
266,916
-7,812
-3% -$693K
CATC
39
DELISTED
CAMBRIDGE BANCORP
CATC
$21.4M 0.94%
258,627
-13,354
-5% -$1.1M
XYL icon
40
Xylem
XYL
$26B
$21.1M 0.93%
270,317
-6,796
-2% -$561K
VRSK icon
41
Verisk Analytics
VRSK
$25B
$20.9M 0.91%
120,552
-1,879
-2% -$350K
VEA icon
42
Vanguard FTSE Developed Markets ETF
VEA
$238B
$20.2M 0.89%
495,769
-132,065
-21% -$5.87M
ORLY icon
43
O'Reilly Automotive
ORLY
$71.6B
$19.9M 0.87%
473,595
-20,265
-4% -$872K
MDT icon
44
Medtronic
MDT
$117B
$19.7M 0.86%
219,177
-929
-0.4% -$94.1K
BDX icon
45
Becton Dickinson
BDX
$51.6B
$19.4M 0.85%
78,677
-3,190
-4% -$810K
MDLZ icon
46
Mondelez International
MDLZ
$79.6B
$19.2M 0.84%
309,194
-584
-0.2% -$36.9K
AGG icon
47
iShares Core US Aggregate Bond ETF
AGG
$138B
$19.1M 0.84%
188,162
-24,665
-12% -$2.53M
RIO icon
48
Rio Tinto
RIO
$168B
$18.9M 0.83%
309,374
+30,919
+11% +$2.22M
NVDA icon
49
NVIDIA
NVDA
$5.25T
$18.5M 0.81%
1,221,870
-13,490
-1% -$255K
ETN icon
50
Eaton
ETN
$156B
$18.4M 0.8%
145,689
+29,351
+25% +$4.11M

Similar funds

Cambridge Trust's Q2 2022 Portfolio in Review

As of Q2 2022, Cambridge Trust held 985 positions worth $2.28B, down 20% from $2.86B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Cambridge Trust withdrew a net $160M in Q2 2022, closing 122 positions and reducing 331 holdings. Its most notable exit was Paycom, an estimated $915K position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Cambridge Trust opened a new position in Chart Industries worth $4.21M.

  • Cambridge Trust's largest Q2 2022 buy was Chart Industries: 25,166 shares worth $4.21M.
  • Cambridge Trust added most to ExxonMobil in Q2 2022, an estimated $13.7M increase.
  • Cambridge Trust's biggest Q2 2022 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $45.1M.
  • Cambridge Trust fully exited Paycom in Q2 2022, selling an estimated $915K.
  • Cambridge Trust's ten largest holdings make up 27% of its $2.28B portfolio in Q2 2022.
  • Cambridge Trust opened 54 new positions and closed 122 in Q2 2022.
  • Cambridge Trust's portfolio value fell 20% quarter-over-quarter to $2.28B.

Based on Cambridge Trust's 13F filing for Q2 2022, filed 16 Aug 2022.